Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Cad. saúde pública ; 31(3): 496-506, 03/2015. tab
Article in English | LILACS | ID: lil-744841

ABSTRACT

This study analyzes the available evidence on the adequacy of economic evaluation for decision-making on the incorporation or exclusion of technologies for rare diseases. The authors conducted a structured literature review in MEDLINE via PubMed, CRD, LILACS, SciELO, and Google Scholar (gray literature). Economic evaluation studies had their origins in Welfare Economics, in which individuals maximize their utilities based on allocative efficiency. There is no widely accepted criterion in the literature to weigh the expected utilities, in the sense of assigning more weight to individuals with greater health needs. Thus, economic evaluation studies do not usually weigh utilities asymmetrically (that is, everyone is treated equally, which in Brazil is also a Constitutional principle). Healthcare systems have ratified the use of economic evaluation as the main tool to assist decision-making. However, this approach does not rule out the use of other methodologies to complement cost-effectiveness studies, such as Person Trade-Off and Rule of Rescue.


El objetivo fue sistematizar las evidencias disponibles sobre la pertinencia de utilizar la evaluación económica para la incorporación/exclusión de tecnología en enfermedades raras. Se realizó una revisión sistemática de la literatura en MEDLINE vía PubMed, CRD, LILACS, SciELO y Google Académico (literatura gris). Los estudios de evaluación económica se originan de la Economía del Bienestar, en la que los individuos maximizan sus utilidades, basándose en la eficiencia de asignación. No existe un criterio ampliamente aceptado para examinar las utilidades, a fin de dar más peso a los individuos con mayores necesidades. Generalmente, los estudios no equilibran asimétricamente las utilidades, todas son consideradas iguales, lo que en Brasil es también un principio constitucional. Los sistemas de salud han ratificado el uso de la evaluación económica como la principal herramienta para ayudar en la toma de decisiones. Sin embargo, este abordaje no excluye el uso de otras metodologías complementarias a los estudios de coste-efectividad, como la técnica de compensación personal o la regla del rescate.


O objetivo deste estudo foi analisar as evidências disponíveis sobre a adequação do uso de avaliação econômica sobre incorporação/exclusão de tecnologias para doenças raras. Foi realizada uma revisão estruturada da literatura, nas bases MEDLINE, via PubMed, CRD, LILACS, SciELO e Google Acadêmico (literatura cinzenta). Os estudos de avaliação econômica têm origem na Economia do Bem-Estar, na qual os indivíduos maximizam suas utilidades, fundamentando-se na eficiência alocativa. Não há um critério amplamente aceito para ponderar as utilidades esperadas, no sentido de dar mais peso aos indivíduos com maiores necessidades em saúde. Geralmente não se ponderam assimetricamente as utilidades; todas são tratadas de forma igualitária, que, no caso brasileiro, também é um princípio constitucional. Os sistemas de saúde têm ratificado o uso de avaliação econômica como principal instrumento para auxiliar na tomada de decisão. No entanto, essa postura não exclui o uso de outras metodologias complementares aos estudos de custo-efetividade, como Person Trade-Off e regra de resgate.


Subject(s)
Animals , Humans , Mice , Atherosclerosis/enzymology , Atherosclerosis/pathology , Foam Cells/enzymology , Matrix Metalloproteinases/metabolism , Aortic Rupture/etiology , Aortic Rupture/prevention & control , Atherosclerosis/complications , Atherosclerosis/immunology , Foam Cells/pathology , Gene Expression Regulation, Enzymologic , Lipid Metabolism , Models, Immunological , Matrix Metalloproteinases/genetics , Myocardial Infarction/complications , Myocardial Infarction/enzymology , Myocardial Infarction/immunology , Myocardial Infarction/pathology , Myocytes, Smooth Muscle/pathology , Tissue Inhibitor of Metalloproteinases/immunology , Tissue Inhibitor of Metalloproteinases/metabolism
2.
Pesqui. bras. odontopediatria clín. integr ; 10(3): 505-511, set.-dez. 2010. ilus
Article in Portuguese | LILACS, BBO | ID: biblio-874864

ABSTRACT

Introdução: A reabsorção fisiológica dos dentes decíduos constitui um fenômeno fisiológico complexo não completamente conhecido; assunto de grande interesse clínico. Os mecanismos celulares e moleculares envolvidos no fenômeno de reabsorção radicular fisiológica parecem ser similares aos mecanismos envolvidos na reabsorção óssea, mediada por osteoclastos. As principais células responsáveis pela reabsorção ativa dos tecidos dentais são os odontoclastos, também denominados de clastos ou osteoclastos; células gigantes multinucleadas originadas de precursores hematopoiéticos de monócitos ou macrófagos. Avanços recentes na literatura específica têm mostrado que a diferenciação e atividade dos osteoclastos, fenômeno também conhecido como osteoclastogênese, são iniciadas e reguladas por diferentes estímulos e sinalizadores moleculares como as citocinas, quimiocinas, produtos de degradação liberados pela superfície radicular afetada, moléculas de adesão, metaloproteinases e pelo sistema RANK/RANKL/OPG. Ainda, o contato físico entre os precursores de osteoclastos e osteoblastos ou células estromais também parece ser necessário para a ativação da osteoclastogênese. Entretanto, o papel específico dos fatores envolvidos no início e modulação da reabsorção radicular dos dentes decíduos permanece desconhecido. Objetivo: Realizar uma revisão de literatura sobre os mecanismos celulares e moleculares envolvidos no processo de reabsorção fisiológica dos dentes decíduos, enfatizando suas implicações clínicas.


Conclusão: Uma complexa interação entre osteclastos, osteoblastos, macrófagos, citocinas, quimiocinas, metaloproteinases, moléculas de adesão e o sistema RANK/RANKL/OPG parecem contribuir para a reabsorção dentária fisiológica. O conhecimento dos mecanismos celulares e moleculares envolvidos no processo de reabsorção fisiológica dos dentes decíduos pode contribuir para o estudo da imunopatogenia das reabsorções dentárias e futuramente resultar na aplicação clínica de mediadores moleculares para atrasar ou mesmo inibir esse processo


Introduction: The physiological resorption of primary teeth is a complex physiological phenomenon that is not completely known and is a subject of great interest. The cellular and molecular mechanisms involved in the phenomenon of physiological root resorption seem to be similar to those involved in bone resorption mediated by osteoclasts. The main cells responsible for the active resorption of the dental tissues are the odontoclasts, which are also known as clasts or osteoclasts; multi nucleated giant cells originated from hematopoietic precursors of monocytes or macrophages. Recent advances published in the literature have shown that the differentiation and activity of osteoclasts, a phenomenon that is also known as osteoclastgenesis, are initiated and regulated by different stimuli and molecular signalizing agents such as cytokines, chemokines, products of degradation released by the affected root surface, adhesion molecules, metalloproteinases, and the RANK/RANKL/OPG system. Moreover, the physical contact between the osteoclasts and osteoblast precursors or stromal cells also seems to be necessary for the activation of osteoclastgenesis. However, the specific role of the factors involved in the initiation and modulation of root resorption of the primary teeth remains unknown. Objective: To perform a review of the literature about the cellular and molecular mechanisms involved in the process of physiological resorption of the primary teeth, emphasizing their clinical implications.


Conclusion: A complex integration among osteoclasts, osteoblasts, macrophages, cytokines, chemokines, metalloproteinases, adhesion molecules and the RANK/RANKL/OPG system seems to contribute to the physiological resorption of teeth. Knowing the cellular and molecular mechanisms involved in the process of physiological root resorption of primary teeth may contribute to the investigation of the immunepathogenesis of dental resorptions, and allow for the clinical application of molecular mediators to delay or even inhibit this process


Subject(s)
Tooth, Deciduous/physiology , Tooth Exfoliation/immunology , Osteoclasts/pathology , Bone Morphogenetic Proteins , Tissue Inhibitor of Metalloproteinases/immunology
3.
Article in English | IMSEAR | ID: sea-139703

ABSTRACT

Background: Porphyromonas gingivalis, an important periodontal pathogen, is closely associated with inflammatory alveolar bone resorption. This bacterium exerts its pathogenic effect indirectly through multiple virulence factors, such as lipopolysaccharides, fimbriae, and proteases. Another possible pathogenic path may be through a direct interaction with the host's soft and hard tissues (e.g., alveolar bone), which could lead to periodontitis. Aims and Objectives: The aim of the present study was to investigate the direct effect of live and heat-inactivated P gingivalis on bone resorption, using an in vitro osteoblast culture model. Results: Optical microscopy and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide MTT assay revealed that live P gingivalis induced osteoblast detachment and reduced their proliferation. This effect was specific to live bacteria and was dependent on their concentration. Live P gingivalis increased IL-6 mRNA expression and protein production and downregulated RANKL and OPG mRNA expression. The effect of live P gingivalis on bone resorption was strengthened by an increase in MMP-9 expression and its activity. This increase was accompanied by an increase in TIMP-1 and TIMP-2 mRNA expression and protein production by osteoblasts infected with live P gingivalis. Conclusion: Overall, the results suggest that direct contact of P gingivalis with osteoblasts induces bone resorption through an inflammatory pathway that involves IL-6, RANKL/OPG, and MMP-9/TIMPs.


Subject(s)
Bone Resorption/immunology , Bone Resorption/microbiology , Cell Adhesion/immunology , Cell Line, Tumor , Cell Proliferation , Coloring Agents/diagnosis , Down-Regulation , Host-Pathogen Interactions/immunology , Humans , Interleukin-6/immunology , Matrix Metalloproteinase 2/immunology , Matrix Metalloproteinase 9/immunology , Osteoblasts/immunology , Osteoblasts/microbiology , Osteoprotegerin/immunology , Porphyromonas gingivalis/immunology , RANK Ligand/immunology , Tetrazolium Salts/diagnosis , Thiazoles/diagnosis , Tissue Inhibitor of Metalloproteinase-1/immunology , Tissue Inhibitor of Metalloproteinase-2/immunology , Tissue Inhibitor of Metalloproteinases/immunology
SELECTION OF CITATIONS
SEARCH DETAIL